Erectile dysfunction drugs market garnered a revenue of USD 5.63 billion in the year 2019 globally and has been foreseen to yield USD 2.94 billion by the year 2027 at a negative compound annual growth (CAGR) of 6.2% over the forecast period. The market has been observed to be growing at a steady growth rate over the last three years, however with the impact of COVID-19 pandemic globally, the business conditions are expected to change. The market size may reduce significantly or increase with a spike depending on how the value chain has been affected in the entire process.
Players that are operational in the market for a longer period of time are anticipated to absorb the sudden changes, losses and increased operational costs better than those who have recently entered the market. The report focuses on numerous factors that are anticipated to impact the market growth directly and indirectly. The report categorically analyses the growth patterns of different segments based on multiple derivation models.
Both the qualitative and quantitative aspects have been covered under the report. The Erectile Dysfunction Drugs market report includes market size, drivers, restraints, opportunities and trends that will help you understand the market dynamics in detail. Moreover, the report will include market estimates & forecasts in terms of revenue for the overall market along with the segments mentioned in the study. The report focuses on providing a holistic view of the entire market scenario from multiple unmatched detailed analysis mentioned in the report.
What to expect from the report?
Erectile Dysfunction Drugs Total Available Market (TAM) Size
Erectile Dysfunction Drugs Serviceable Available Market (SAM) Size
Business Implications of COVID-19 on the Overall Market
Market Share/ Revenue Share (%) of Top Market Players in Total Market Size (2019)
Market Size & Forecast (2016-2027) At Country & Regional Level, By Segments
Overview & Analysis of Key Players Operating in the Market
Global market revenue in 2020 will be derived taking into various micro & macro level factors; along with COVID-19 pandemic
Competitive Analysis
Company Market Share Analysis, 2019 (%)
Supply Chain Analysis
Analysis pertaining to several participants of supply chain such as raw material suppliers, distributors, & OEMs along with others will be highlighted in the study
Data Source
Primary & Secondary Research, Internal Data Base & Company Annual Reports
Regions Included
North America, Europe, Asia Pacific, Latin America, & Middle East & Africa
Countries Included
U.S., Canada, U.K., Germany, France, Mexico, Brazil, China, India, Japan, South Korea, UAE, South Africa
Table of Contents Chapter 1. Research Methodology & Data Sources 1.1. Data Analysis Models 1.2. Research Scope & Assumptions 1.3. List of Primary & Secondary Data Sources Chapter 2. Executive Summary Chapter 3. Erectile Dysfunction Drugs Market: Industry Analysis 3.1. Market segmentation 3.2. Supply chain analysis 3.3. Porter’s 5 forces analysis 3.4. PEST analysis 3.5. Market Dynamics 3.5.1. Market driver analysis 3.5.2. Market restraint analysis 3.5.3. Market opportunity analysis 3.6. Company Market Share Analysis, 2019 Chapter 4. Erectile Dysfunction Drugs Market: Product Insights 4.1. Global Product Historic Market Data & Future Forecasts, 2016-2027 4.2. Viagra 4.2.1. Historic Market Data & Future Forecasts, 2016-2027 4.2.2. Historic Market Data & Future Forecasts by Region, 2016-2027 4.3. Levitra/Staxyn 4.3.1. Historic Market Data & Future Forecasts, 2016-2027 4.3.2. Historic Market Data & Future Forecasts by Region, 2016-2027 4.4. Stendra/Spedra 4.4.1. Historic Market Data & Future Forecasts, 2016-2027 4.4.2. Historic Market Data & Future Forecasts by Region, 2016-2027 4.5. Zydena 4.5.1. Historic Market Data & Future Forecasts, 2016-2027 4.5.2. Historic Market Data & Future Forecasts by Region, 2016-2027 4.6. Vitaros 4.6.1. Historic Market Data & Future Forecasts, 2016-2027 4.6.2. Historic Market Data & Future Forecasts by Region, 2016-2027 Chapter 5. Erectile Dysfunction Drugs Market: Regional Insights 5.1. Global Erectile Dysfunction Drugs Market Data & Future Forecasts, By Region 2016-2027 5.2. North America 5.2.1. Historic Market Data & Future Forecasts, 2016-2027 5.2.2. Historic Market Data & Future Forecasts, By Product, 2016-2027 5.2.3. U.S. 5.2.3.1. Historic Market Data & Future Forecasts, 2016-2027 5.2.3.2. Historic Market Data & Future Forecasts, By Product, 2016-2027 5.2.4. Canada 5.2.4.1. Historic Market Data & Future Forecasts, 2016-2027 5.2.4.2. Historic Market Data & Future Forecasts, By Product, 2016-2027 5.3. Europe 5.3.1. Historic Market Data & Future Forecasts, 2016-2027 5.3.2. Historic Market Data & Future Forecasts, By Product, 2016-2027 5.3.3. U.K. 5.3.3.1. Historic Market Data & Future Forecasts, 2016-2027 5.3.3.2. Historic Market Data & Future Forecasts, By Product, 2016-2027 5.3.4. Germany 5.3.4.1. Historic Market Data & Future Forecasts, 2016-2027 5.3.4.2. Historic Market Data & Future Forecasts, By Product, 2016-2027 5.3.5. France 5.3.5.1. Historic Market Data & Future Forecasts, 2016-2027 5.3.5.2. Historic Market Data & Future Forecasts, By Product, 2016-2027 5.4. Asia Pacific 5.4.1. Historic Market Data & Future Forecasts, 2016-2027 5.4.2. Historic Market Data & Future Forecasts, By Product, 2016-2027 5.4.3. China 5.4.3.1. Historic Market Data & Future Forecasts, 2016-2027 5.4.3.2. Historic Market Data & Future Forecasts, By Product, 2016-2027 5.4.4. India 5.4.4.1. Historic Market Data & Future Forecasts, 2016-2027 5.4.4.2. Historic Market Data & Future Forecasts, By Product, 2016-2027 5.4.5. Japan 5.4.5.1. Historic Market Data & Future Forecasts, 2016-2027 5.4.5.2. Historic Market Data & Future Forecasts, By Product, 2016-2027 5.4.6. South Korea 5.4.6.1. Historic Market Data & Future Forecasts, 2016-2027 5.4.6.2. Historic Market Data & Future Forecasts, By Product, 2016-2027 5.5. Latin America 5.5.1. Historic Market Data & Future Forecasts, 2016-2027 5.5.2. Historic Market Data & Future Forecasts, By Product, 2016-2027 5.5.3. Brazil 5.5.3.1. Historic Market Data & Future Forecasts, 2016-2027 5.5.3.2. Historic Market Data & Future Forecasts, By Product, 2016-2027 5.5.4. Mexico 5.5.4.1. Historic Market Data & Future Forecasts, 2016-2027 5.5.4.2. Historic Market Data & Future Forecasts, By Product, 2016-2027 5.6. Middle East & Africa 5.6.1. Historic Market Data & Future Forecasts, 2016-2027 5.6.2. Historic Market Data & Future Forecasts, By Product, 2016-2027 5.6.3. UAE 5.6.3.1. Historic Market Data & Future Forecasts, 2016-2027 5.6.3.2. Historic Market Data & Future Forecasts, By Product, 2016-2027 5.6.4. South Africa 5.6.4.1. Historic Market Data & Future Forecasts, 2016-2027 5.6.4.2. Historic Market Data & Future Forecasts, By Product, 2016-2027 Chapter 6. Company Profiles 6.1. Vivus, Inc. 6.1.1. Company Description 6.1.2. Financial Highlights 6.1.3. Product Portfolio 6.1.4. Strategic Initiatives 6.2. S.K. Chemicals Co. Ltd. 6.2.1. Company Description 6.2.2. Financial Highlights 6.2.3. Product Portfolio 6.2.4. Strategic Initiatives 6.3. Pfizer, Inc. 6.3.1. Company Description 6.3.2. Financial Highlights 6.3.3. Product Portfolio 6.3.4. Strategic Initiatives 6.4. Meda Pharmaceuticals, Inc. 6.4.1. Company Description 6.4.2. Financial Highlights 6.4.3. Product Portfolio 6.4.4. Strategic Initiatives 6.5. Eli Lilly and Company 6.5.1. Company Description 6.5.2. Financial Highlights 6.5.3. Product Portfolio 6.5.4. Strategic Initiatives 6.6. Dong-A Pharmaceutical Co. Ltd. 6.6.1. Company Description 6.6.2. Financial Highlights 6.6.3. Product Portfolio 6.6.4. Strategic Initiatives 6.7. Cristalia Produtos Quimicos Farmaceuticos Ltd. 6.7.1. Company Description 6.7.2. Financial Highlights 6.7.3. Product Portfolio 6.7.4. Strategic Initiatives 6.8. Bayer AG 6.8.1. Company Description 6.8.2. Financial Highlights 6.8.3. Product Portfolio 6.8.4. Strategic Initiatives 6.9. Apricus Biosciences Inc. 6.9.1. Company Description 6.9.2. Financial Highlights 6.9.3. Product Portfolio 6.9.4. Strategic Initiatives List of Tables Table 1 Erectile Dysfunction Drugs Market Market Data & Future Forecasts, 2016-2027 (USD Billion) Table 2 Erectile Dysfunction Drugs Market Data & Future Forecasts, By Region, 2016-2027 (USD Billion) Table 3 Erectile Dysfunction Drugs Market Data & Future Forecasts, By Product, 2016-2027 (USD Billion) Table 4 Viagra Market Data & Future Forecasts, 2016-2027 (USD Billion) Table 5 Levitra/Staxyn Market Data & Future Forecasts, 2016-2027 (USD Billion) Table 6 Stendra/Spedra Market Data & Future Forecasts, 2016-2027 (USD Billion) Table 7 Zydena Market Data & Future Forecasts, 2016-2027 (USD Billion) Table 8 Vitaros Market Data & Future Forecasts, 2016-2027 (USD Billion) Table 9 North America Erectile Dysfunction Drugs Market Data & Future Forecasts, 2016-2027 (USD Billion) Table 10 North America Erectile Dysfunction Drugs Market Data & Future Forecasts, By Product, 2016-2027 (USD Billion) Table 11 U.S. Erectile Dysfunction Drugs Market Data & Future Forecasts, 2016-2027 (USD Billion) Table 12 U.S. Erectile Dysfunction Drugs Market Data & Future Forecasts, By Product, 2016-2027 (USD Billion) Table 13 Canada Erectile Dysfunction Drugs Market Data & Future Forecasts, 2016-2027 (USD Billion) Table 14 Canada Erectile Dysfunction Drugs Market Data & Future Forecasts, By Product, 2016-2027 (USD Billion) Table 15 Europe Erectile Dysfunction Drugs Market Data & Future Forecasts, 2016-2027 (USD Billion) Table 16 Europe Erectile Dysfunction Drugs Market Data & Future Forecasts, By Product, 2016-2027 (USD Billion) Table 17 U.K. Erectile Dysfunction Drugs Market Data & Future Forecasts, 2016-2027 (USD Billion) Table 18 U.K Erectile Dysfunction Drugs Market Data & Future Forecasts, By Product, 2016-2027 (USD Billion) Table 19 Germany Erectile Dysfunction Drugs Market Data & Future Forecasts, 2016-2027 (USD Billion) Table 20 Germany Erectile Dysfunction Drugs Market Data & Future Forecasts, By Product, 2016-2027 (USD Billion) Table 21 France Erectile Dysfunction Drugs Market Data & Future Forecasts, 2016-2027 (USD Billion) Table 22 France Erectile Dysfunction Drugs Market Data & Future Forecasts, By Product, 2016-2027 (USD Billion) Table 23 Asia Pacific Erectile Dysfunction Drugs Market Data & Future Forecasts, 2016-2027 (USD Billion) Table 24 Asia Pacific Erectile Dysfunction Drugs Market Data & Future Forecasts, By Product, 2016-2027 (USD Billion) Table 25 China Erectile Dysfunction Drugs Market Data & Future Forecasts, 2016-2027 (USD Billion) Table 26 China Erectile Dysfunction Drugs Market Data & Future Forecasts, By Product, 2016-2027 (USD Billion) Table 27 India Erectile Dysfunction Drugs Market Data & Future Forecasts, 2016-2027 (USD Billion) Table 28 India Erectile Dysfunction Drugs Market Data & Future Forecasts, By Product, 2016-2027 (USD Billion) Table 29 Japan Erectile Dysfunction Drugs Market Data & Future Forecasts, 2016-2027 (USD Billion) Table 30 Japan Erectile Dysfunction Drugs Market Data & Future Forecasts, By Product, 2016-2027 (USD Billion) Table 31 South Korea Erectile Dysfunction Drugs Market Data & Future Forecasts, 2016-2027 (USD Billion) Table 32 South Korea Erectile Dysfunction Drugs Market Data & Future Forecasts, By Product, 2016-2027 (USD Billion) Table 33 Latin America Erectile Dysfunction Drugs Market Data & Future Forecasts, 2016-2027 (USD Billion) Table 34 Latin America Erectile Dysfunction Drugs Market Data & Future Forecasts, By Product, 2016-2027 (USD Billion) Table 35 Brazil Erectile Dysfunction Drugs Market Data & Future Forecasts, 2016-2027 (USD Billion) Table 36 Brazil Erectile Dysfunction Drugs Market Data & Future Forecasts, By Product, 2016-2027 (USD Billion) Table 37 Mexico Erectile Dysfunction Drugs Market Data & Future Forecasts, 2016-2027 (USD Billion) Table 38 Mexico Erectile Dysfunction Drugs Market Data & Future Forecasts, By Product, 2016-2027 (USD Billion) Table 39 Middle East & Africa Erectile Dysfunction Drugs Market Data & Future Forecasts, 2016-2027 (USD Billion) Table 40 Middle East & Africa Erectile Dysfunction Drugs Market Data & Future Forecasts, By Product, 2016-2027 (USD Billion) Table 41 UAE Erectile Dysfunction Drugs Market Data & Future Forecasts, 2016-2027 (USD Billion) Table 42 UAE Erectile Dysfunction Drugs Market Data & Future Forecasts, By Product, 2016-2027 (USD Billion) Table 43 South Africa Erectile Dysfunction Drugs Market Data & Future Forecasts, 2016-2027 (USD Billion) Table 44 South Africa Erectile Dysfunction Drugs Market Data & Future Forecasts, By Product, 2016-2027 (USD Billion) List of Figures Fig.1 Data Analysis Model Fig.2 Erectile Dysfunction Drugs Market, by 2016-2027 (USD Billion) Fig.3 Erectile Dysfunction Drugs Market Segmentation Fig.4 Supply chain analysis Fig.5 Erectile Dysfunction Drugs Market Driver Anlaysis Fig.6 Erectile Dysfunction Drugs Market Restraint Analysis Fig.7 Erectile Dysfunction Drugs Market Opportunity Analysis Fig.8 Porters 5 Forces Model Fig.9 PEST Analysis- Erectile Dysfunction Drugs Market Fig.10 Company Market Share Analysis, 2019
Erectile Dysfunction Drugs Market Segmentation:
Erectile Dysfunction Drugs Market, By Product (2016-2027)
Viagra
Levitra/Staxyn
Stendra/Spedra
Zydena
Vitaros
Erectile Dysfunction Drugs Market, By Region (2016-2027)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Asia Pacific
China
India
Japan
South Korea
Latin America
Brazil
Mexico
Middle East & Africa
UAE
South Africa
Major Players Operating in the Erectile Dysfunction Drugs Market:
Vivus, Inc.
K. Chemicals Co. Ltd.
Pfizer, Inc.
Meda Pharmaceuticals, Inc.
Eli Lilly and Company
Dong-A Pharmaceutical Co. Ltd.
Cristalia Produtos Quimicos Farmaceuticos Ltd.
Bayer AG
Apricus Biosciences Inc.
Frequently Asked Questions About This Report
Choose License Type
Each market study on Reports Globe will be revised based on COVID-19 impact analysis
How can we help you?
Our salient features
Best Solution
We will help you understand value propositions of various reports across numerous domains and suggest the best possible solution to suffice your research needs.
Customized Research
Our team of analysts and consultants provide assistance for customized research requirements
Max ROI
Guaranteed maximum assistance to help you get your reports at the optimum prices, thereby ensuring maximum returns on investment.
24/7 Support
24X7 availability to help you through the buying process as well as answer any of your doubts.
